Downfield Proton MRSI at 3 Tesla: A Pilot Study in Human Brain Tumors.

İpek ÖzdemirDavid O KamsonSemra EtyemezLindsay BlairDoris Da May Lin Peter B Barker

Published in: Cancers (2023)

3D DF-MRSI in human brain tumors at 3T is feasible and was well tolerated by all patients enrolled in this preliminary study. Amide levels measured by 3D DF-MRSI were significantly different between treatment effect and tumor regrowth.

Keyphrases

endothelial cells
end stage renal disease
induced pluripotent stem cells
ejection fraction
chronic kidney disease
newly diagnosed
pluripotent stem cells
patient reported outcomes
patient reported
combination therapy